Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Gorilla and King Portfolio Candidates -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (3610)	7/9/1999 4:01:00 PM
From: LLCF	Respond to of 54805

<AFFX up $8 to $66 and still no comments from anybody on the thread? Clearly the current members of the Gorilla thread are interested only in non-bioTech,> How about INCY as well Mike? Why don't we really come up with a strong arguement ala "Sandisk" earlier on this thread and come back. These two stocks have enabling technologies, may very well be Gorilla's, get GREAT prices for their tools [including royalties on future drugs developed using them, in INCY's case!] and are NOT biotechs! They ARE technology stocks and have emerging technologies with little competition. I'll do INCY and you do AFFX. DAK DAK